Why the study?
High-sensitivity troponin I can be elevated in noncardiac conditions such as acute cholecystitis, presenting a diagnostic challenge in patients with abdominal pain and abnormal ECGs.
Does high-sensitivity troponin I testing improve the detection or exclusion of myocardial injury compared to conventional troponin in patients with acute cholecystitis and abnormal ECGs?
Does high-sensitivity troponin I testing improve the detection or exclusion of myocardial injury compared to conventional troponin in patients with acute cholecystitis and abnormal ECGs?
High-sensitivity troponin I can be elevated in acute cholecystitis and is useful for stratifying risk and excluding myocardial injury in patients presenting with abdominal pain and abnormal ECGs.
Answers are grounded in this paper and cite their sources.
hs-TnI may aid ED interpretation in abdominal pain with abnormal ECGs; leaves open prospective validation before practice change.
Abdominal pain is a common chief complaint in Emergency departments (EDs) nationwide which presents a wide array of potential etiologies including acute coronary syndrome ( Daniels et al., 2020 ). High-sensitivity troponin I (hs-TnI), a biomarker traditionally linked to cardiac injury, can also be elevated in noncardiac conditions, such as acute cholecystitis. This case study underscores the advantages of hs-TnI over conventional troponin tests, specifically among patients with abnormal ECGs. This case also highlights the hs-TnI superior sensitivity in detecting or excluding subtle myocardial injuries that may arise from conditions like acute cholecystitis ( Babic et al., 2012 ). By integrating hs-TnI into the diagnostic workup, advanced practice registered nurses can more effectively stratify patient risk, thereby enhancing the quality of early diagnosis and management of acute cholecystitis.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: